Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
Announcements
for
Cipla Ltd
03:52 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
09:48 AM
Cipla Receives U.S. FDA Approval For First AB Rated Generic Of Ventolin?? HFA
04:30 PM
USFDA Inspection At Company'S Manufacturing Facility In Goa, India
07:54 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
03:35 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
05:53 PM
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
07:32 PM
Board Meeting Intimation for The Quarter And Year Ended 31St March, 2026 Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
06:22 PM
Announcement under Regulation 30 (LODR)-Resignation of Director
06:18 PM
Announcement under Regulation 30 (LODR)-Change in Management
08:54 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
10:13 PM
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
08:38 PM
General Updates
05:39 PM
Corporate Action-Amalgamation/ Merger / Demerger
05:35 PM
Announcement under Regulation 30 (LODR)-Acquisition
05:32 PM
Announcement under Regulation 30 (LODR)-Change in Directorate
07:26 PM
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
10:52 PM
Update On US Food And Drug Administration (USFDA) Inspection On Pharmathen International S.A.
08:07 PM
Announcement under Regulation 30 (LODR)-Acquisition
07:30 PM
Announcement under Regulation 30 (LODR)-Acquisition
05:20 PM
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
04:10 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
08:53 PM
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
05:52 PM
Update On US Food And Drug Administration (USFDA) Inspection On Pharmathen International S.A.
05:57 PM
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
07:24 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08:43 AM
USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA
10:25 PM
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
06:46 PM
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
05:34 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10:07 AM
Announcement under Regulation 30 (LODR)-Change in Management
06:24 PM
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
07:41 PM
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
01:00 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
07:20 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
02:16 PM
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
02:10 PM
Announcement under Regulation 30 (LODR)-Change in Directorate
02:08 PM
Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 23Rd January, 2026
01:42 PM
Announcement under Regulation 30 (LODR)-Investor Presentation
01:40 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release
01:27 PM
Financial Results For Quarter And Nine Months Ended 31St December, 2025
05:49 PM
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11:11 PM
Update On Lanreotide Supply Pursuant To US Food And Drug Administration (USFDA) Inspectional Observations In Form 483 On Pharmathen International S.A.
04:40 PM
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06:33 PM
Reply On Clarification Sought By Exchange
06:13 PM
Intimation Under Regulation 30(11) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Clarification On USFDA Inspectional Observations In Form 483 On Pharmathen International S.A.
04:11 PM
Clarification sought from Cipla Ltd
03:12 PM
Announcement under Regulation 30 (LODR)-Change in Management
08:25 PM
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Friday, 23Rd January, 2026 Inter-Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December, 2025.
07:10 PM
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
11:31 AM
Cipla Limited Has Entered Into Exclusive Supply And Marketing Agreement For Pfizer'S Brands
05:59 PM
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
10:24 PM
Announcement under Regulation 30 (LODR)-Updates on Acquisition
12:50 PM
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
05:49 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
06:44 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
03:31 PM
Product Launch - Lilly And Cipla Sign Marketing And Distribution Agreement For Second Brand Of Tirzepatide In India
03:51 PM
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
01:32 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
04:41 PM
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday, 30Th October, 2025.
06:50 PM
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
04:40 PM
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
07:15 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08:18 PM
Announcement under Regulation 30 (LODR)-Updates on Acquisition
07:42 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
06:31 PM
Intimation Of Cancellation Of Schedule Of Analyst / Institutional Investor Meetings
06:33 PM
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
09:10 AM
Update On USFDA Inspection At Company''s Manufacturing Facility In Bommasandra, Bengaluru, India
10:53 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
10:19 PM
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
06:02 PM
Clarification On The News Item Dated 1St August 2025 Titled 'Pharma Stocks Slump As Trump Shoots Letters To 17 Global Drug Majors Seeking Lower Prices' Appearing In 'Www.Moneycontrol.Com'
01:29 PM
Clarification sought from Cipla Ltd
06:26 PM
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
06:38 PM
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
12:08 AM
Announcement under Regulation 30 (LODR)-Newspaper Publication
05:19 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
01:34 PM
Announcement under Regulation 30 (LODR)-Press Release / Media Release
01:29 PM
Announcement under Regulation 30 (LODR)-Investor Presentation
01:26 PM
Grant Of Esops/Esars
01:21 PM
Board Meeting Outcome for Financial Results For Quarter Ended 30Th June 2025
01:19 PM
Financial Results For Quarter Ended 30Th June 2025
07:13 PM
Transcript Of The 89Th Annual General Meeting
07:28 PM
Announcement under Regulation 30 (LODR)-Acquisition
01:19 PM
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
10:37 PM
Announcement under Regulation 30 (LODR)-Change in Management
10:34 PM
Shareholder Meeting / Postal Ballot-Outcome of AGM
10:31 PM
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
07:39 PM
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
05:18 PM
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
05:31 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
07:51 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
06:45 PM
Board Meeting Intimation for Quarter Ended 30Th June, 2025 Under SEBI Listing Regulations
06:09 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10:08 AM
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
04:50 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
09:19 PM
Business Responsibility and Sustainability Reporting (BRSR)
09:14 PM
Notice Of 89Th Annual General Meeting And Integrated Annual Report For FY 2024-25
09:10 PM
Reg. 34 (1) Annual Report.
08:26 PM
Announcement under Regulation 30 (LODR)-Newspaper Publication
05:38 PM
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
08:46 PM
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
View announcements
for all companies
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist